About MedAvante-ProPhase
MedAvante-ProPhase is a Healthcare company based in Hamilton (United States) founded in 2002 by Paul Gilbert, and was acquired by WIRB-Copernicus Group in May 2017. It operates as an eSource data capture solutions are provided for clinical trials. MedAvante-ProPhase has raised $2.29 million across 1 funding round from investors including WIRB-Copernicus Group and Arsenal Capital Partners. MedAvante-ProPhase offers products and services including IRB Review, Site Enablement, and Clinical Endpoints. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Suvoda, Circuit Clinical, HumanFirst, Curavit and Raylytic and 3 more; 6 of its 8 listed competitors have raised funding.
Company details
MedAvante-ProPhase was founded in 2002 and is based in Hamilton, United States. Operations focus on the healthcare technology sector, where eSource data capture and electronic data management systems are offered for clinical trials. The flagship Virgil Investigative Study Platform is utilized for signal detection, incorporating tablet-based interfaces with context-sensitive rating scales and clinical guidance tailored to specific studies. Services support data integrity and efficiency in trial processes.
- Headquarters Hamilton, United States
- Founders Paul Gilbert
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website medavante-prophase.com
- Social LinkedIn X
- Acquired by WIRB-Copernicus Group (May 2017)
- Total Equity Funding$2.29M (USD)
in 1 rounds
- Latest Funding Round$2.29M (USD), Series A
Oct 2015
- InvestorsWIRB-Copernicus Group
& 1 more
- Acquired byWIRB-Copernicus Group
(May 2017)
Products & Services of MedAvante-ProPhase
MedAvante-ProPhase offers a comprehensive portfolio of products and services, including IRB Review, Site Enablement, and Clinical Endpoints.
Service for ethical and scientific review of clinical trials
Platform for site preparation and operational support
Tools for monitoring and assessing trial outcomes
Funding Insights of MedAvante-ProPhase
MedAvante-ProPhase has successfully raised a total of $2.29M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.29 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.29M
- Total Rounds 1
- Last Round Series A — $2.29M
- First Round $2.29M
(Oct 2015)
All 1 funding rounds of MedAvante-ProPhase with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | $2.29M | Series A | – | – | – |
2 investors in total: 2 institutional.
Investors in MedAvante-ProPhase
MedAvante-ProPhase has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include WIRB-Copernicus Group and Arsenal Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments target specialty industrials and healthcare sectors. | 2000 | arsenalcapital.com | New York, United States | |
Regulatory and ethical review services for clinical research are provided. | 2012 | wcgclinical.com | Princeton, United States |
Investor details for MedAvante-ProPhase
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MedAvante-ProPhase
380 people are tracked at MedAvante-ProPhase (135 in leadership, 1 in board & advisors, 244 in team).
| Name | Role | Group |
|---|---|---|
Paul Gilbert | Co-Founder | Leadership |
Russell John | Senior Director, Business Intelligence And Benchmarking | Leadership |
Ron Thornton | Vice President Of Business Development And General Manager Of Velos, LLC | Leadership |
Jared Zane | Chief Legal Officer & Corporate Secretary | Leadership |
Jill Johnston | Chief Innovation Officer | Leadership |
Paul Halas | Director Of Business Development | Leadership |
Jillian Milam | Director Of Business Development | Leadership |
McPaul Ogbonna | Director, Business Development | Data Analytics & Consulting | Leadership |
Geoffrey Schick Mba, Chrc | Director, Strategic Site Partnerships | Leadership |
Daniel F. | Associate Director, Project Governance | Leadership |
Stacey Rumerman | Senior Director, Clinical Science | Leadership |
Joseph Mumma | Vice President, Quality Assurance, Technology | Leadership |
Jessica Blankenship | Senior Director, Quality | Leadership |
Sana Ansari | Director, Business Development | Leadership |
Sam Srivastava | Chief Executive Officer | Leadership |
Robert Vanhees | CFO & Chief Administrative Officer | Leadership |
Carmin Gade | Chief Marketing Officer | Leadership |
Lisa Calicchio | Chief Human Capital Management Officer | Leadership |
Mark McDonald | President, Ethical Review Division, WCG | Leadership |
Alexandra de Jong | Director Of Platform Governance And Operational Excellence | Leadership |
360 more people are available in the full profile.
Complete people profiles for MedAvante-ProPhase
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MedAvante-ProPhase
3 dated milestones of MedAvante-ProPhase across 15 years, from founding to its latest funding, stage changes and deals.
- Founded MedAvante-ProPhase is founded.
- Funding First funding round of $2.3M.
- Exit Acquired by WIRB-Copernicus Group.
Competitors of MedAvante-ProPhase
MedAvante-ProPhase has 8 listed competitors in our database, 6 of them funded. They include Suvoda, Circuit Clinical, HumanFirst, Curavit and Raylytic, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| suvoda.com | 2012 | Conshohocken, United States | $40M | 302 | Clinical trial management solutions are provided through Suvoda's IRT system. | |
| circuitclinical.com | 2014 | Buffalo, United States | $47.67M | – | Research site network platform focuses on patient identification, enrollment, recruitment & retention | |
| gohumanfirst.com | 2017 | San Francisco, United States | $14.9M | 344 | HumanFirst is integrated into ICON, focusing on digital health solutions. | |
| curavit.io | 2019 | Boston, United States | $16.43M | – | Contract research organization that offers a complete suite of CRO services for decentralized clinical trials | |
| raylytic.com | 2017 | Leipzig, Germany | – | 25 | Solutions for medical image analysis, data management, workflow automation & EPR collection | |
| signetaccel.com | 2014 | Columbus, United States | $8M | 28 | Data management tools are supplied to the healthcare sector. | |
| tritrials.com | 2013 | Raleigh, United States | – | 55 | ICH Rev 2 compliance and risk-based monitoring solutions are provided. | |
| bio-optronics.com | 1985 | Rochester, United States | $30M | – | Clinical trial management systems are provided for healthcare workflow optimization. |
Detailed competitors of MedAvante-ProPhase
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as MedAvante-ProPhase (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MedAvante-ProPhase
MedAvante-ProPhase was founded in 2002 and raised its 1st funding round 13 years after it was founded.
MedAvante-ProPhase is headquartered in Hamilton, United States.
MedAvante-ProPhase is a funded company, having raised a total of $2.29M across 1 funding round to date. The company's 1st funding round was a Series A of $2.29M, raised on Oct 2015.
MedAvante-ProPhase was founded in 2002 and is based in Hamilton, United States. Operations focus on the healthcare technology sector, where eSource data capture and electronic data management systems are offered for clinical trials. The flagship Virgil Investigative Study Platform is utilized for signal detection, incorporating tablet-based interfaces with context-sensitive rating scales and clinical guidance tailored to specific studies. Services support data integrity and efficiency in trial processes.
MedAvante-ProPhase's top competitors include Suvoda, HumanFirst and Circuit Clinical.
MedAvante-ProPhase offers IRB Review, Site Enablement, and Clinical Endpoints.
MedAvante-ProPhase has 2 investors. Key investors include WIRB-Copernicus Group, and Arsenal Capital Partners.
Yes. MedAvante-ProPhase was acquired by WIRB-Copernicus Group in May 2017.